000 | 00834 a2200253 4500 | ||
---|---|---|---|
005 | 20250516014358.0 | ||
264 | 0 | _c20110103 | |
008 | 201101s 0 0 cze d | ||
022 | _a0042-773X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPenka, M | |
245 | 0 | 0 |
_a[Rivaroxaban and factor Xa inhibitors in clinical practice]. _h[electronic resource] |
260 |
_bVnitrni lekarstvi _cSep 2010 |
||
300 |
_a920-6 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 | _aFactor Xa Inhibitors |
650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMorpholines _xtherapeutic use |
650 | 0 | 4 | _aRivaroxaban |
650 | 0 | 4 |
_aThiophenes _xtherapeutic use |
650 | 0 | 4 |
_aThrombosis _xdrug therapy |
773 | 0 |
_tVnitrni lekarstvi _gvol. 56 _gno. 9 _gp. 920-6 |
|
999 |
_c20427983 _d20427983 |